Streamlining Yield, Quality, Scalability and Compliance of Plasmid and Cell-free DNA Production Platforms to Meet the Increasing Global Demand for High-Quality DNA, RNA, Cell & Gene Therapies
Welcome to the Inaugural DNA Process Development and Manufacturing Summit
Trailblazing DNA Platforms with Speed & Quality for Better Genetic Medicines
With the cell and gene therapy industry surging, rapid advances in mRNA-based therapies, and the advent of DNA vaccines, the demand for quality DNA as a critical starting and therapeutic material has skyrocketed in recent years.
The Inaugural DNA Process Development and Manufacturing Summit is the only forum solely dedicated to increasing plasmid and cell-free based DNA production while reducing costs, time, and ensuring regulatory compliance.
Meet 80+ DNA production experts over 3 days packed with deep-dive workshops, data-led presentations, and dedicated discussion and networking sessions to address the most pressing challenges of producing DNA, brought together by our 18+ expert speakers from leading companies like Sanofi, Roche, Genentech, Pfizer and more.
If you want to gain higher yields of top-quality DNA while reducing costs and time, then this summit is for you!
World-Class Speaker Faculty Includes:
Proud to Partner with:
Michael Homsy
Senior Scientist
Merck & Co
"This meeting is an opportunity to learn from experts and have valuable discussions on the critical challenges we face"
"This meeting is a valuable opportunity to bring scientists, biopharmaceutical manufacturers, suppliers and regulators together to focus on advancements and opportunities in the field of DNA manufacturing, to seek knowledge exchange and alignment for these important materials. "
Basak Clements
Global Head of Material
Science, Pharma
Technology Cell & Gene
Therapy
Genentech
